ENTITY
Jacobson Pharma

Jacobson Pharma (2633 HK)

16
Analysis
Health Care • Hong Kong
Jacobson Pharma is a leading pharmaceutical company primarily engaged in the research, development, production, sale, and distribution of essential medicines and specialty drugs. It operates through Generic Drugs and Branded Healthcare segments, offering a broad portfolio of off-patent medicines, proprietary Chinese medicines, and health and wellness products. The company is headquartered in Kwun Tong, Hong Kong, and was incorporated in 2016.
more
•18 Mar 2020 12:02

Trade Idea: Short Henlius Upon Lock-Up Expiry & 2H Results, HLX01 Likely Underperformed

Shanghai Henlius Biotech (2696 HK) IPO lock-up will expire on 25th of March, six months post its listing. The stock has been underwater since...

Logo
548 Views
Share
•20 Jan 2020 09:33

Hong Kong Buyback Weekly: Xingyi Glass, Yichang HEC, Consun Pharma

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
489 Views
Share
•31 Dec 2019 10:36

Hong Kong Buyback Weekly: Bosideng, Jacobson, Duiba

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
676 Views
Share
bullish•Jacobson Pharma
•13 Sep 2016 12:23

Jacobson Pharma IPO -- Home Team Advantage

Jacobson Pharmaceutical Corporation Limited is a pending listing on the HKEX. This Insight forks Toh Zhen Zhou 's Insight Jacobson Pharma IPO -...

Share
x